Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, if his Department will instruct health providers to update outdated or unclear information on hormone replacement therapy treatments for menopause.

Setting guidance for the treatment of individual conditions falls to the National Institute for Health and Care Excellence (NICE), who produce guidance for the National Health Service and wider health and care system. NICE guidelines are evidence-based recommendations for health and care in England and Wales. They help health and social care professionals to prevent ill health, promote good health, and improve the quality of care and services.

NICE clinical guidelines are intended for health and social care professionals, commissioners, patients, and carers to help them make informed decisions on the appropriate treatment and care.

When put into practice, NICE guidelines have the potential to effectively target health and care resources to significantly improve patient outcomes, in line with the best available evidence of clinical and cost-effectiveness. Although healthcare professionals and commissioners are not legally obliged to follow NICE guidelines, they are expected to take them into full account when making decisions on treatment and care for patients. The most recent guidance, last updated November 2024, is available at the following link:

https://www.nice.org.uk/guidance/ng23

Generally, providers rely on a range of professional organisations to keep their practice up to date, and they need to work within a scope of practice which includes being up to date and which is assessed through appraisal. In addition to NICE, they would look to the British Menopause Society, the College of Sexual and Reproductive Healthcare, the Royal College of General Practitioners, or the Royal College of Obstetricians and Gynaecologists. Further information on the British Menopause Society is available at the following link:

https://thebms.org.uk/